Invention Grant
- Patent Title: Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer
-
Application No.: US16522391Application Date: 2019-07-25
-
Publication No.: US11306154B2Publication Date: 2022-04-19
- Inventor: Maria Amann , Peter Bruenker , Christina Claus , Claudia Ferrara Koller , Sandra Grau-Richards , Christian Klein , Viktor Levitski , Ekkehard Moessner , Joerg Thomas Regula , Pablo Umana
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agent Robin A. Weatherhead
- Priority: EP14193260 20141114,EP15183736 20150903,EP15188142 20151002
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/28 ; C07K14/705 ; A61K39/395 ; A61K38/00 ; C07K16/30

Abstract:
The invention relates to novel TNF family ligand trimer-containing antigen binding molecules comprising (a) at least one moiety capable of specific binding to a target cell antigen and (b) a first and a second polypeptide that are linked to each other by a disulfide bond, characterized in that the first polypeptide comprises two ectodomains of a TNF ligand family member or fragments thereof that are connected to each other by a peptide linker and in that the second polypeptide comprises only one ectodomain of said TNF ligand family member or a fragment thereof.
Public/Granted literature
- US20200247904A1 ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER Public/Granted day:2020-08-06
Information query